Summary
Machine-generated summaryTechniker Krankenkasse (TK) in Germany intends to conclude rebate contracts under Section 130a paragraph 8 of the German Social Code, Book V (SGB V) for the active substance ranibizumab. The procedure is an open house model: individual negotiations on contract terms are not conducted, uniform conditions apply to all participants, and no exclusivity is granted to individual partners. Pharmaceutical entrepreneurs are eligible to participate. The contract runs for a maximum of 12 months starting on 01.07.2026 and ends no later than 30.06.2027, regardless of the date of contract conclusion. Further details are provided in the participation and contract documents.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago
More from this buyer
Full buyer profile6 open tenders right now
- Medicines - Open-House Biosimilar Discount Agreements 2025-31 - Denosumab 430 days left
- Medicines - Open-house discount agreements 2025-06 552 days left
- Pharmaceuticals - Open-House rebate contracts 2025-06 553 days left
This buyer has no award history in this sector yet. Usual winners, Medical equipment & pharmaceuticals - Germany
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| Siemens Healthineers AG | 42 | €17.4M | Sep 2026 |
| Philips GmbH | 20 | €5.3M | Sep 2026 |
| GlaxoSmithKline GmbH & Co. KG | 15 | n/a | Sep 2026 |
| ASTRAZENECA GMBH | 12 | n/a | Jul 2026 |
| Brainlab Sales GmbH | 10 | €4.0M | Sep 2026 |
Based on 1018 awards with a linked company profile over the last 2 years.
Similar tenders
2
days left
€2,750,000
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €10,113,211
- Buyer track record on Aperlena
- 6 notices tracked · 0 awarded
Never miss a tender like this
76 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.
Set up my alert